Hormone therapy's reputation was shaped heavily by a single 2002 study — the Women's Health Initiative — that triggered widespread fear and a sharp drop in prescriptions. Decades of follow-up research and re-analysis since then have significantly changed the picture, but the fear has been slower to update than the science. Here's where the evidence actually stands today.
What Changed Since the Original Study
The original 2002 findings were widely reported without important context: the average participant was 63 years old and more than a decade past menopause, and the study used an older formulation and route of hormones. Subsequent analysis, including the "timing hypothesis," found that starting hormone therapy closer to menopause onset — rather than a decade or more later — carries a different, generally more favorable risk profile. Current major medical societies, including the North American Menopause Society, support hormone therapy as a reasonable, evidence-based option for many symptomatic women, particularly within 10 years of menopause onset.
What the Real Risks Are
Hormone therapy is not risk-free, and being direct about that matters. Depending on the formulation, route of administration, and individual health history, risks can include a modestly increased risk of blood clots, and for some formulations, a small increased breast cancer risk with long-term use. These risks vary meaningfully based on the type of hormone, the delivery method (oral versus transdermal, for instance), dose, and the individual's personal and family health history — which is exactly why an individualized evaluation matters more than a blanket yes-or-no answer.
Who Should Be Cautious or Avoid Hormone Therapy
- History of certain hormone-sensitive cancers
- History of blood clots or certain clotting disorders
- Uncontrolled cardiovascular disease
- Active or recent liver disease
- Undiagnosed abnormal vaginal bleeding
What About Testosterone Therapy for Men?
Testosterone replacement therapy carries its own, separate safety profile. Current evidence, including the large-scale TRAVERSE cardiovascular safety trial, has generally not shown the cardiovascular risk increase that was once a major concern for appropriately screened, monitored men. That said, testosterone therapy does require monitoring — red blood cell count, prostate-specific antigen, and lipid panels — and isn't appropriate for men with certain prostate conditions or uncontrolled sleep apnea without further evaluation.
What Responsible Treatment Looks Like
The safety of hormone therapy depends heavily on proper screening, individualized dosing, appropriate formulation choice, and ongoing monitoring — not a one-size-fits-all prescription. A thorough evaluation reviews personal and family history, runs relevant baseline labs, and reassesses regularly rather than starting and forgetting.
"The research has moved a lot further than public perception has. For the right patient, properly screened and monitored, hormone therapy is one of the most well-studied and evidence-supported treatments we offer — the outdated fear does more harm than the actual therapy does."
The Bottom Line
Hormone therapy is not risk-free, and it's not right for everyone — but current evidence supports it as a safe, effective option for many appropriately screened patients, women and men alike. The right next step is an individualized evaluation, not a decision based on decades-old headlines.
Have Questions About Hormone Therapy Safety?
We'll review your full history, run the right labs, and give you an honest, individualized answer about whether hormone therapy makes sense for you.
This article is for educational purposes only and does not constitute medical advice. Please consult a qualified physician before starting any new treatment. — Justin Abbott, D.O., Abbott Health & Wellness, 45 North State Street, Salina, UT 84654.